3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Radiation Injuries
1
Interventions
Cyclophosphamide
2043
Radiotherapy
1859
Cisplatin
1826
Carboplatin
1533
Gemcitabine
1435
Paclitaxel
1291
Bevacizumab
1271
Docetaxel
1202
pembrolizumab
1201
Oxaliplatin
1160
Capecitabine
1145
Fluorouracil
1061
Dexamethasone
971
Rituximab
919
Nivolumab
908
Magnetic Resonance Spectroscopy
864
Etoposide
839
Doxorubicin
823
Drug Therapy
792
Radiosurgery
776
Irinotecan
775
Cytarabine
736
fludarabine
716
Leucovorin
676
Lenalidomide
609
fludarabine phosphate
564
Temozolomide
552
Radiation
541
Filgrastim
540
Cetuximab
537
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
Adenosine Diphosphate
×
Clear all
NCT03109080
2025-11-24
RadioPARP
Institut Curie
Phase 1
Completed
24 enrolled